A device to measure liver health using advanced imaging technology
Point-of Care MR Device to Estimate T1 Relaxation Time as a Biomarker of Liver Disease (resubmission)
['FUNDING_SBIR_1'] · LIVIVOS INC. · NIH-10760778
This study is testing a new, easy-to-use device called the LiverScope® that helps doctors quickly check liver health, especially for people with conditions like nonalcoholic fatty liver disease, so they can get better care without needing special equipment.
Quick facts
| Phase | ['FUNDING_SBIR_1'] |
|---|---|
| Study type | Nih_funding |
| Sex | All |
| Sponsor | LIVIVOS INC. (nih funded) |
| Locations | 1 site (San Diego, UNITED STATES) |
| Trial ID | NIH-10760778 on ClinicalTrials.gov |
What this research studies
This research focuses on developing the LiverScope®, a portable and user-friendly device designed to assess liver health by estimating T1 relaxation times, a key biomarker for liver diseases such as nonalcoholic fatty liver disease (NAFLD). The device utilizes advanced magnetic resonance technology that does not require specialized room shielding, allowing it to be used in standard clinical settings or even in mobile units. By providing quick and accurate assessments, this device aims to improve the diagnosis and monitoring of liver conditions, ultimately enhancing patient care. The research will evaluate the feasibility of this technology in clinical settings, paving the way for future comprehensive trials.
Who could benefit from this research
Good fit: Ideal candidates for this research include individuals at risk for nonalcoholic fatty liver disease or those already diagnosed with liver conditions.
Not a fit: Patients with liver diseases that are not related to fatty liver or those who are not at risk for liver conditions may not benefit from this research.
Why it matters
Potential benefit: If successful, this research could provide a non-invasive, accessible method for early diagnosis and monitoring of liver diseases, improving patient outcomes.
How similar studies have performed: Other research has shown promise in using advanced imaging techniques for liver disease assessment, indicating that this approach could be effective.
Where this research is happening
San Diego, UNITED STATES
- LIVIVOS INC. — San Diego, UNITED STATES (ACTIVE)
Researchers
- Principal investigator: PRADO, PABLO J — LIVIVOS INC.
- Study coordinator: PRADO, PABLO J
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.